INVO BioScience, Inc. (INVO) Financials
INVO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 19.5 million | 19.1 million |
| 2023-06-30 | 6.6 million | 8.3 million |
| 2023-03-31 | 4.1 million | 5.1 million |
| 2022-12-31 | 4.1 million | 5.1 million |
INVO Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -1.4 million | 265473 |
| 2023-06-30 | -1.9 million | 426254 |
| 2023-03-31 | -1.0 million | 412199 |
| 2022-12-31 | -1.0 million | 412199 |
INVO Net Income
No data available :(
INVO Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 1.1 million | - | 6.0 million |
| 2023-06-30 | 112485 | - | 4.1 million |
| 2023-03-31 | 90135 | - | 1.8 million |
| 2022-12-31 | - | - | 1.9 million |
INVO Shares Outstanding
INVO Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | 108217 | 2668 | 1.3 million | - |
| 2023-06-30 | 261505 | 83850 | 2.0 million | - |
| 2023-03-31 | 135 | 73835 | 2.5 million | - |
| 2022-12-31 | 135 | 73835 | 2.8 million | - |
INVO Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | 974894 | 580968 |
| 2023-06-30 | 315902 | 255419 |
| 2023-03-31 | 278142 | 79194 |
| 2022-12-31 | 278142 | 79194 |
INVO
Price: $0.93
52 week price:
Earnings Per Share: -10.34 USD
P/E Ratio: -0.09
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Volume: 111179
Market Capitalization: 2.1 million